The streptozotocin-treated Sprague-Dawley rat: a useful model for the assessment of acute and chronic effects of myocardial ischaemia reperfusion injury in experimental diabetes

1. Bolognese L , Carrabba N , Santoro GM. et al. Angiographic findings, time course of regional and global left ventricular function, and clinical outcome in diabetic patients with acute myocardial infarction treated with primary percutaneous transluminal coronary angioplasty. Am J Cardiol 2003;91:544–9.

2. Adeghate E. Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review. Mol Cell Biochem 2004;261:187–91.

3. Bhindi R , Witting PK , McMahon AC , Khachigian LM , Lowe HC. Rat models of myocardial infarction. Pathogenetic insights and clinical relevance. Thromb Haemost 2006;96:602–10.

4. Chen D , Wang MW. Development and application of rodent models for type 2 diabetes. Diabetes Obes Metab 2005;7:307–17.

5. Qi JS , Kam KW , Chen M , Wu S , Wong TM. Failure to confer cardio-protection and to increase the expression of heat-shock protein 70 by preconditioning with a kappa-opioid receptor agonist during ischaemia and reperfusion in streptozotocin-induced diabetic rat. Diabetologia 2004;47:214–20.

6. Adameova A , Kuzelova M , Andelova E. et al. Hypercholesterolemia abrogates an increased resistance of diabetic rat hearts to ischemia-reperfusion injury. Mol Cell Biochem 2007;295:129–36.

7. Rees DA , Alcolado JC. Animal models of Diabetes mellitus. Diabetes Med 2005;22:359–70.

8. Wayman NS , McDonald MC , Chatterjee PK , Thiemermann C. Models of coronary artery occlusion and reperfusion for the discovery of novel antiischemic and antiinflammatory drugs for the heart. Methods Mol Biol 2003;225:199–208.

9. Chimenti S , Carlo E , Masson S , Bai A , Latini R. Myocardial infarction: animal models. Methods Mol Med 2004;98:217–26.